Oncopro EGFR Rapid Test sale cost 3510 AED
Cancer Targeted Gene Panel Colon Colorectal Test sale cost 2970 AED Cancer Targeted Gene Panel Colon Colorectal Test Cost 3,960 د.إ Original price was: 3,960 د.إ.2,970 د.إCurrent price is: 2,970 د.إ.
LPL Expert Panel 2 Test sale cost 3280 AED LPL Expert Panel 2 Test Cost 3,640 د.إ Original price was: 3,640 د.إ.3,280 د.إCurrent price is: 3,280 د.إ.
Sale!

Oncopro EGFR Rapid Test Cost

Original price was: 3,900 د.إ.Current price is: 3,510 د.إ.

-10%

The Oncopro EGFR Rapid Test is a cutting-edge diagnostic tool designed for the swift and accurate detection of mutations in the Epidermal Growth Factor Receptor (EGFR) gene. These mutations are crucial biomarkers in the diagnosis and treatment planning for various types of cancer, particularly non-small cell lung cancer (NSCLC). By identifying specific EGFR mutations, oncologists can tailor treatment strategies to target the genetic underpinnings of a patient’s cancer, potentially improving outcomes and reducing the likelihood of adverse effects from less targeted therapies.

Performed at DNA Labs UAE, a leading facility in genetic testing and personalized medicine, the Oncopro EGFR Rapid Test leverages advanced molecular techniques to analyze a patient’s DNA sample—usually obtained from a biopsy or a liquid biopsy—for the presence of EGFR mutations. This rapid test provides results faster than traditional genomic sequencing methods, enabling timely decision-making in clinical settings.

The cost of the Oncopro EGFR Rapid Test at DNA Labs UAE is set at 3510 AED. While the price may be considered high for some, the value it provides in guiding the precise treatment of cancer can be invaluable. Patients are encouraged to discuss with their healthcare providers whether this test is appropriate for their specific situation and to explore insurance coverage or financial assistance programs that may help offset the cost.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

ONCOPRO EGFR RAPID Test – Cost, Symptoms, Diagnosis

Welcome to DNA Labs UAE, where we offer the ONCOPRO EGFR Rapid Test for the diagnosis of certain types of cancer. This test can help determine the most appropriate treatment options for patients. Read on to learn more about the test, its cost, symptoms, diagnosis, and more.

Test Details

The ONCOPRO EGFR Rapid Test is a diagnostic test used to detect mutations in the epidermal growth factor receptor (EGFR) gene. EGFR mutations are commonly found in certain types of cancer, such as non-small cell lung cancer (NSCLC). This test is designed to provide quick and accurate results, allowing healthcare professionals to make informed decisions about patient care.

Test Components

  • Test Name: ONCOPRO EGFR RAPID Test
  • Price: 3510.0 AED
  • Sample Condition: Submit formalin fixed paraffin embedded (FFPE) tissue block. Ship at room temperature. Block should have at least 10% tumor tissue.
  • Report Delivery: Sample Daily by 11am; Report Next Working day
  • Method: Real Time PCR
  • Test Type: Cancer
  • Doctor: Oncologist
  • Test Department: MOLECULAR DIAGNOSTICS
  • Pre Test Information: Block should have at least 10% tumor tissue.

How the Test Works

The ONCOPRO EGFR Rapid Test is based on the principle of polymerase chain reaction (PCR) technology. It amplifies and detects specific DNA sequences, targeting EGFR mutations commonly associated with NSCLC, such as exon 19 deletions and the L858R point mutation in exon 21. The test kit typically includes all the necessary reagents and materials for performing the test, including PCR primers, DNA polymerase, and a detection system. The process involves extracting DNA from a patient’s tissue or blood sample, amplifying the EGFR gene region of interest using PCR, and then analyzing the amplified DNA for the presence of specific mutations.

Benefits and Treatment

The results of the ONCOPRO EGFR Rapid Test can help guide treatment decisions, such as whether a patient is a candidate for targeted therapies like tyrosine kinase inhibitors (TKIs). EGFR mutations are predictive biomarkers for the effectiveness of these drugs, and identifying them can help improve patient outcomes. Overall, the ONCOPRO EGFR Rapid Test is a valuable tool in the management of cancer patients, allowing for efficient and accurate detection of EGFR mutations to guide personalized treatment strategies.

For more information or to schedule a test, please contact DNA Labs UAE.

Test Name ONCOPRO EGFR RAPID Test
Components
Price 3510.0 AED
Sample Condition Submit formalin fixed paraffin embedded (FFPE) tissue block.Ship at room temperature. Block should have atleast 10% tumor tissue.
Report Delivery Sample Daily by 11am; Report Next Working day
Method Real Time PCR
Test type Cancer
Doctor Oncologist
Test Department: MOLECULAR DIAGNOSTICS
Pre Test Information Block should have atleast 10% tumor tissue.
Test Details

The ONCOPRO EGFR Rapid Test is a diagnostic test used to detect mutations in the epidermal growth factor receptor (EGFR) gene. EGFR mutations are commonly found in certain types of cancer, such as non-small cell lung cancer (NSCLC), and can help determine the most appropriate treatment options for patients.

The test is designed to provide quick and accurate results, allowing healthcare professionals to make informed decisions about patient care. It utilizes a simple and user-friendly testing process, making it accessible for both laboratory and point-of-care settings.

The ONCOPRO EGFR Rapid Test is based on the principle of polymerase chain reaction (PCR) technology, which amplifies and detects specific DNA sequences. It specifically targets EGFR mutations commonly associated with NSCLC, such as exon 19 deletions and the L858R point mutation in exon 21.

The test kit typically includes all the necessary reagents and materials for performing the test, including PCR primers, DNA polymerase, and a detection system. The process involves extracting DNA from a patient’s tissue or blood sample, amplifying the EGFR gene region of interest using PCR, and then analyzing the amplified DNA for the presence of specific mutations.

The results of the ONCOPRO EGFR Rapid Test can help guide treatment decisions, such as whether a patient is a candidate for targeted therapies like tyrosine kinase inhibitors (TKIs). EGFR mutations are predictive biomarkers for the effectiveness of these drugs, and identifying them can help improve patient outcomes.

Overall, the ONCOPRO EGFR Rapid Test is a valuable tool in the management of cancer patients, allowing for efficient and accurate detection of EGFR mutations to guide personalized treatment strategies.

SKU: TEST-4727 Category:

Related products